IL21 and neoplasm: Early preclinical studies leveraged the overexpression of IL-21 directly in transplanted tumors or systemic administration of IL-21 plasmid DNA by hydrodynamic-mediated methods, and both of these delivery methods significantly reduced tumor growth in an NK cell- and T-cell-dependent manner (119, 121).